Rumination and Escaping Depression | Professor David Nutt | PSYCH Symposium: London 2022

Psychedelic medicines bind to 5H2TA receptors to cause psychoactive effects. At PSYCH Symposium: London 2022, Awakn Life Science's Chief Research Officer, Professor David Nutt, outlined the neuroscience behind their ability to alter states of consciousness. About PSYCH: PSYCH is a data and insights platform for the psychedelic healthcare industry. As our collective understanding of and attitudes towards psychedelics shift dramatically, we are witnessing a global rise in clinical trials, academic research and commercial investment. PSYCH tracks key psychedelic players, innovations and milestones, providing market insights to help investors make informed decisions. Psychedelics are poised to disrupt the way we approach healthcare. To learn more about PSYCH, access our industry-leading events, subscribe to the most widely read psychedelics industry newsletter, or download The Psychedelics as Medicine Report. Web: https://psych.global/ Twitter:   / psychglobal_   LinkedIn:   / psych%e2%84%a2